Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations [Cell line]

ABSTRACT: SCLC is molecularly and immunologically heterogenous. Here, using transcriptional and epigenomic profiling of plastic SCLC states in human and mouse cell lines, and patient samples, we define the phenotype of a SCLC population marked by increased MHC Class I antigen presentation.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE168294 | GEO | 2021/03/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations

Project description:SCLC is molecularly and immunologically heterogenous. Here, using transcriptional and epigenomic profiling of plastic SCLC states in human and mouse cell lines, and patient samples, we define the phenotype of a SCLC population marked by increased MHC Class I antigen presentation.

2021-03-04 | GSE168195 | GEO

Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations [patient]

2021-03-05 | GSE168266 | GEO

Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations

Project description:Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations

| PRJNA706431 | ENA

Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations

Project description:Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations

| PRJNA706756 | ENA

Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-03-05 | GSE168295 | GEO

Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations [patient]

Project description:Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations [patient]

| PRJNA706705 | ENA

Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations [Cell line]

Project description:Identification of intrinsically immunogenic small cell lung carcinoma (SCLC) subpopulations [Cell line]

| PRJNA706757 | ENA

Gene expression profiling of neuroendocrine (NE) and non-neuroendocrine (non-NE) cells derived from ex vivo cultures of small cell lung cancer (SCLC) circulating tumour cell-derived explant (CDX) model

Project description:To determine molecular processes in vasculogenic mimicry (VM) competent human SCLC CDX, we profiled gene expression by RNA sequencing in separated NE (VM deficient) and non-NE (VM competent) cells from four CDX cultured on plastic or on Matrigel.

2023-10-23 | GSE240789 | GEO

Unbiased proteomic profiling uncovers a targetable GNAS/PKA/PP2A axis in SCLC

Project description:Using unbiased kinase profiling, we identified protein kinase A (PKA) as an active kinase in small cell lung cancer (SCLC). Inhibition of PKA activity genetically, or pharmacologically by activation of the PP2A phosphatase, inhibits SCLC expansion in culture and in vivo. Conversely, GNAS (G-protein α subunit), a PKA activator that is genetically activated in a small subset of human SCLC, promotes SCLC development. Phosphoproteomic analyses identified many new PKA substrates and mechanisms of action. In particular, PKA activity is required for the propagation of SCLC cancer stem cells in transplantation studies. Broad proteomic analysis of recalcitrant cancers has the potential to uncover novel targetable signaling networks, such as the GNAS/PKA/PP2A axis in SCLC.

2020-06-17 | PXD018209 | Pride

PAX5 promotes progression of SCLC

Project description:RNAseq of SCLC cell line H1155 with PAX5.knocked out. The goals of this study are to identify the function of PAX5 in SCLC.

2021-01-31 | GSE135439 | GEO